Question 1

What are the potential benefits and risks of teriparatide compared to zoledronic acid?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my bone health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the side effects I should be aware of for each treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate, and what does that involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific eligibility requirements I should know about?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens after the initial 12 months of treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women clinical trial (NCT00927186). Contact the study team or your healthcare provider for specific answers.

What this study is about